Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SZSE:301033's Days Inventory is ranked worse than 51.65% of 790
companies
in the Medical Devices & Instruments industry
Industry Median: 177.215
vs SZSE:301033: 181.92
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medprin Regenerative Medical Technologies Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medprin Regenerative Medical Technologies Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.40.
Medprin Regenerative Medical Technologies Co (SZSE:301033) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medprin Regenerative Medical Technologies Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medprin Regenerative Medical Technologies Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medprin Regenerative Medical Technologies Co Days Inventory Related Terms
Medprin Regenerative Medical Technologies Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co Days Inventory Chart
Medprin Regenerative Medical Technologies Co Annual Data
SZSE:301033 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medprin Regenerative Medical Technologies Co Days Inventory vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co (SZSE:301033) has a Days Inventory of 143.52 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. This is 41% below median its historical median of 242.56. Over the past decade, Medprin Regenerative Medical Technologies Co's Days Inventory has ranged from 178.54 to 295.64. According to the industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #408 out of 790 companies in the Medical Devices & Instruments industry, placing it in the top 51.6%.
Is Medprin Regenerative Medical Technologies Co's Days Inventory too high?
Medprin Regenerative Medical Technologies Co's current Days Inventory of 143.52 is 41% below median its 10-year median of 242.56. Over the past 10 years, this metric has ranged from a low of 178.54 to a high of 295.64. The Medical Devices & Instruments industry median Days Inventory is 177.22. Medprin Regenerative Medical Technologies Co's value of 143.52 is 19% below this industry median. Based on the distribution chart, Medprin Regenerative Medical Technologies Co ranks #408 out of 790 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medprin Regenerative Medical Technologies Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medprin Regenerative Medical Technologies Co's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #408 out of 790 companies for Days Inventory. This places Medprin Regenerative Medical Technologies Co in the lower half of its industry. The industry median Days Inventory is 177.22. Medprin Regenerative Medical Technologies Co's value of 143.52 is 19% below this benchmark. Historically, Medprin Regenerative Medical Technologies Co's own Days Inventory has ranged from 178.54 to 295.64 over the past decade. While the company's 10-year median is 242.56 vs. the industry median of 177.22, Medprin Regenerative Medical Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 177.22, based on 790 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medprin Regenerative Medical Technologies Co's current Days Inventory of 143.52 is 19% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 177.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medprin Regenerative Medical Technologies Co's current Days Inventory is 143.52, which is 41% below median its own 10-year median of 242.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medprin Regenerative Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co (SZSE:301033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥73.38, compared to a current price of ¥53.02 — trading 27.7% below its estimated fair value. The current Days Inventory is 143.52, which is 41% below median its 10-year median of 242.56 and 19% below the Medical Devices & Instruments industry median of 177.22. Medprin Regenerative Medical Technologies Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medprin Regenerative Medical Technologies Co (SZSE:301033), the current Days Inventory is 143.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medprin Regenerative Medical Technologies Co (SZSE:301033) Overvalued in 2026?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥53.02 is trading 27.7% below its estimated GF Value™ of ¥73.38.
GuruFocus considers Medprin Regenerative Medical Technologies Co to be Modestly Undervalued.
Key valuation signals for SZSE:301033:
Days Inventory: 143.52 (41% below median its 10-year median of 242.56)
GF Value™: ¥73.38 vs. price of ¥53.02 (27.7% below fair value)
Industry Position: 19% below the Medical Devices & Instruments median (#408 of 790)
No single metric tells the full story. See the SZSE:301033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301033 has been successfully added to your 
